Incidence of amyotrophic lateral sclerosis in three counties in western Washington state.

PubWeight™: 1.47‹?› | Rank: Top 5%

🔗 View Article (PMID 8757041)

Published in Neurology on August 01, 1996

Authors

V McGuire1, W T Longstreth, T D Koepsell, G van Belle

Author Affiliations

1: Department of Epidemiology, University of Washington, Seattle, USA.

Associated clinical trials:

Confirmation of Self-Reported Incident ALS Cases in the AARP-Diet and Health (AARP-DH) Cohort | NCT00377351

Articles citing this

Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry (2009) 3.35

Genome-wide analysis of the heritability of amyotrophic lateral sclerosis. JAMA Neurol (2014) 2.22

Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology (2013) 1.76

Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study. J Neurol Neurosurg Psychiatry (2005) 1.47

Association of ALS with head injury, cigarette smoking and APOE genotypes. J Neurol Sci (2010) 1.34

Metabolomic analysis and signatures in motor neuron disease. Metabolomics (2005) 1.31

The incidence of motor nueron disease in Scotland. J Neurol (2007) 1.28

The PRO-ACT database: design, initial analyses, and predictive features. Neurology (2014) 1.26

Smoking and risk of amyotrophic lateral sclerosis: a pooled analysis of 5 prospective cohorts. Arch Neurol (2011) 1.23

Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol (2015) 1.13

The Role of immune and inflammatory mechanisms in ALS. Curr Mol Med (2011) 1.05

Genes and Environmental Exposures in Veterans with Amyotrophic Lateral Sclerosis: the GENEVA study. Rationale, study design and demographic characteristics. Neuroepidemiology (2008) 1.05

The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials. Amyotroph Lateral Scler (2010) 0.99

Racial differences in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener (2013) 0.97

ALS drug development: reflections from the past and a way forward. Neurotherapeutics (2008) 0.96

Clinical neurogenetics: amyotrophic lateral sclerosis. Neurol Clin (2013) 0.96

Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival. Epidemiol Rev (2014) 0.95

The heritability of amyotrophic lateral sclerosis in a clinically ascertained United States research registry. PLoS One (2011) 0.91

Population-based surveillance of amyotrophic lateral sclerosis in New Jersey, 2009-2011. Neuroepidemiology (2014) 0.91

Environmental risk factors and amyotrophic lateral sclerosis (ALS): a case-control study of ALS in Michigan. PLoS One (2014) 0.89

Racial and ethnic differences among amyotrophic lateral sclerosis cases in the United States. Amyotroph Lateral Scler Frontotemporal Degener (2014) 0.86

Projected increase in amyotrophic lateral sclerosis from 2015 to 2040. Nat Commun (2016) 0.83

Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin. Eur J Epidemiol (2015) 0.83

State and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance. Amyotroph Lateral Scler Frontotemporal Degener (2015) 0.81

Association of UBQLN1 mutation with Brown-Vialetto-Van Laere syndrome but not typical ALS. Neurobiol Dis (2012) 0.81

From animal models to human disease: a genetic approach for personalized medicine in ALS. Acta Neuropathol Commun (2016) 0.80

Epidemiology and surveillance of amyotrophic lateral sclerosis in two large metropolitan areas in California. Amyotroph Lateral Scler Frontotemporal Degener (2015) 0.80

Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates. Hum Gene Ther (2016) 0.79

Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis. Int J Epidemiol (2016) 0.78

Amyotrophic Lateral Sclerosis and Metabolomics: Clinical Implication and Therapeutic Approach. J Biomark (2013) 0.76

Amyotrophic lateral sclerosis and parkinsonism in Papua, Indonesia: 2001-2012 survey results. BMJ Open (2014) 0.76

Model systems of motor neuron diseases as a platform for studying pathogenic mechanisms and searching for therapeutic agents. Acta Naturae (2015) 0.75

Race/ethnicity, socioeconomic status, and ALS mortality in the United States. Neurology (2016) 0.75

Articles by these authors

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52

Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med (1996) 8.52

The risk of myocardial infarction associated with antihypertensive drug therapies. JAMA (1995) 7.31

Patient-physician racial concordance and the perceived quality and use of health care. Arch Intern Med (1999) 6.38

Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian and New Zealand Council on Resuscitation, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Asia, and the Resuscitation Council of Southern Africa); the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; and the Stroke Council. Circulation (2008) 5.97

Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91

Validating administrative data in stroke research. Stroke (2002) 5.90

Genomewide association studies of stroke. N Engl J Med (2009) 5.29

A general method of compliance assessment using centralized pharmacy records. Description and validation. Med Care (1988) 4.71

Home use of automated external defibrillators for sudden cardiac arrest. N Engl J Med (2008) 4.64

Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics (2001) 4.30

Bicycle helmet use by children. Evaluation of a community-wide helmet campaign. JAMA (1989) 4.21

Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ (2009) 3.91

Effect of a ban on carrying firearms on homicide rates in 2 Colombian cities. JAMA (2000) 3.91

Cognitive impairment and decline are associated with carotid artery disease in patients without clinically evident cerebrovascular disease. Ann Intern Med (2004) 3.66

Effectiveness of a violence prevention curriculum among children in elementary school. A randomized controlled trial. JAMA (1997) 3.50

Lessons from a trial of acupuncture and massage for low back pain: patient expectations and treatment effects. Spine (Phila Pa 1976) (2001) 3.36

The clinical efficacy of magnetic resonance imaging in neuroimaging. Ann Intern Med (1994) 3.33

Association of lower continuity of care with greater risk of emergency department use and hospitalization in children. Pediatrics (2001) 3.21

Prognosis in amyotrophic lateral sclerosis: a population-based study. Neurology (2003) 3.14

Absence of association between insurance copayments and delays in seeking emergency care among patients with myocardial infarction. N Engl J Med (1997) 3.12

Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology (2001) 3.07

Effects of electronic fetal-heart-rate monitoring, as compared with periodic auscultation, on the neurologic development of premature infants. N Engl J Med (1990) 3.04

Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med (1994) 3.04

Incidence and outcome of injury in Ghana: a community-based survey. Bull World Health Organ (1999) 3.01

The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults. J Am Geriatr Soc (1997) 2.98

Aspartame ingestion and headaches: a randomized crossover trial. Neurology (1994) 2.91

Respiratory epithelial cell invasion by group B streptococci. Infect Immun (1992) 2.86

Statin therapy and risk of dementia in the elderly: a community-based prospective cohort study. Neurology (2004) 2.83

Midlife and late-life obesity and the risk of dementia: cardiovascular health study. Arch Neurol (2009) 2.79

Neighborhood socioeconomic disadvantage and mortality after stroke. Neurology (2013) 2.74

Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc (1999) 2.71

Post-cardiac arrest syndrome: epidemiology, pathophysiology, treatment, and prognostication. A Scientific Statement from the International Liaison Committee on Resuscitation; the American Heart Association Emergency Cardiovascular Care Committee; the Council on Cardiovascular Surgery and Anesthesia; the Council on Cardiopulmonary, Perioperative, and Critical Care; the Council on Clinical Cardiology; the Council on Stroke. Resuscitation (2008) 2.63

Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology (2001) 2.55

Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology (1994) 2.51

White matter hyperintensity on cranial magnetic resonance imaging: a predictor of stroke. Stroke (2004) 2.50

Evidence for a non-linear relationship between leg strength and gait speed. Age Ageing (1996) 2.49

Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37

Elevated risk of stroke among patients with end-stage renal disease. Kidney Int (2003) 2.35

Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) J Neuropathol Exp Neurol (1994) 2.34

Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24

Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA (1999) 2.21

The association between the purchase of a handgun and homicide or suicide. Am J Public Health (1997) 2.19

Pilot randomized clinical trial of prehospital induction of mild hypothermia in out-of-hospital cardiac arrest patients with a rapid infusion of 4 degrees C normal saline. Circulation (2007) 2.18

Risk factors for amputation in patients with diabetes mellitus. A case-control study. Ann Intern Med (1992) 2.18

State gun safe storage laws and child mortality due to firearms. JAMA (1997) 2.16

Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood (1997) 2.15

Does owning a firearm increase or decrease the risk of death? JAMA (1998) 2.14

Sulcal, ventricular, and white matter changes at MR imaging in the aging brain: data from the cardiovascular health study. Radiology (1997) 2.13

Relationship of hearing impairment to dementia and cognitive dysfunction in older adults. JAMA (1989) 2.11

Increased platelet membrane fluidity as a diagnostic marker for Alzheimer's disease: a test in population-based cases and controls. Neurology (1992) 2.08

Nicotine from edible Solanaceae and risk of Parkinson disease. Ann Neurol (2013) 2.08

Clinical course of spontaneous subarachnoid hemorrhage: a population-based study in King County, Washington. Neurology (1993) 2.07

Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology (1989) 2.03

Prospective study of alcohol consumption and risk of dementia in older adults. JAMA (2003) 1.98

Parkinson's disease risks associated with cigarette smoking, alcohol consumption, and caffeine intake. Am J Epidemiol (2002) 1.97

Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation to the development of Alzheimer's disease. Epidemiology (2001) 1.96

The effect of Medicare's payment system for rehabilitation hospitals on length of stay, charges, and total payments. N Engl J Med (1997) 1.95

Alcohol use and risk of ischemic stroke among older adults: the cardiovascular health study. Stroke (2005) 1.94

A prospective study of household smoking bans and subsequent cessation related behaviour: the role of stage of change. Tob Control (2004) 1.93

The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology (1993) 1.89

White matter grade and ventricular volume on brain MRI as markers of longevity in the cardiovascular health study. Neurobiol Aging (2006) 1.88

Cystatin C and subclinical brain infarction. J Am Soc Nephrol (2005) 1.88

Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke (2007) 1.84

Attitudes toward bicycle helmet ownership and use by school-age children. Am J Dis Child (1990) 1.82

Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet (2012) 1.81

Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79

Primary and secondary prevention of alcohol problems: U.S. internist attitudes and practices. J Gen Intern Med (1995) 1.77

The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers. JAMA (1990) 1.76

Vascular events, mortality, and preventive therapy following ischemic stroke in the elderly. Neurology (2005) 1.76

Gait variability is associated with subclinical brain vascular abnormalities in high-functioning older adults. Neuroepidemiology (2007) 1.74

Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol (1997) 1.73

Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology (2004) 1.72

Atrial fibrillation and cognitive decline: a longitudinal cohort study. Neurology (2013) 1.71

University of Washington Alzheimer's Disease Patient Registry (ADPR): 1987-1988. Aging (Milano) (1990) 1.71

US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol (2000) 1.71

Epidemiology of intracranial meningioma. Cancer (1993) 1.70

Do-not-attempt-resuscitation orders and prognostic models for intraparenchymal hemorrhage. Crit Care Med (2011) 1.67

Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology (2003) 1.66

Fecundity before disease onset in women with rheumatoid arthritis. Arthritis Rheum (1993) 1.64

Reducing barriers for implementation of bystander-initiated cardiopulmonary resuscitation: a scientific statement from the American Heart Association for healthcare providers, policymakers, and community leaders regarding the effectiveness of cardiopulmonary resuscitation. Circulation (2008) 1.63

Risk of stroke in young women and two prothrombotic mutations: factor V Leiden and prothrombin gene variant (G20210A) Stroke (1998) 1.63

Journal reading habits of internists. J Gen Intern Med (2000) 1.63

The influence of types of decision support on physicians' decision making. Arch Dis Child (2009) 1.62

Visual impairment and cognitive dysfunction in Alzheimer's disease. J Gen Intern Med (1991) 1.61

The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. Arch Intern Med (1994) 1.60

Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med (1987) 1.59

The association between head trauma and Alzheimer's disease. Am J Epidemiol (1990) 1.58